In conclusion, we hereby assign PAR2 as part of the gene signature which may serve as a predictor of ovarian cancer, highly expressed in the FTs of BRCA1/2 patients as opposed to there being none in normal tissues of FT. This evidence concerns the gene BRCA1 and ovarian carcinoma.